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Abstract
Background—The Hedgehog (Hh) pathway provides inductive signals critical for
developmental patterning of the brain and face. In humans as well as in animal model systems,
interference with this pathway yields birth defects; among the most well-studied of which fall
within the holoprosencephaly (HPE) spectrum.
Methods—Timed-pregnant C57Bl/6J mice were treated with the natural Hh signaling antagonist
cyclopamine by subcutaneous infusion from gestational day (GD) 8.25 to GD 9.5, or with a potent
cyclopamine-analog, AZ75, administered by oral gavage at GD 8.5. Subsequent embryonic
morphogenesis and fetal CNS phenotype were respectively investigated by scanning electron
microscopy and high resolution magnetic resonance imaging (MRI).
Results—In utero Hh signaling antagonist exposure induced a spectrum of craniofacial and brain
malformations. Cyclopamine exposure caused lateral cleft lip and cleft palate (CLP) defects
attributable to embryonic deficiency of midline and lower medial nasal prominence tissue. The
CLP phenotype was accompanied by olfactory bulb hypoplasia and anterior pituitary aplasia but
otherwise grossly normal brain morphology. AZ75 exposure caused alobar and semilobar HPE
with associated median facial deficiencies. An intermediate phenotype of median CLP was
produced infrequently by both drug administration regimens.
Conclusions—The results of this study suggest that interference with Hh signaling should be
considered in the CLP differential and highlight the occurrence of CNS defects as are expected to
be present in a cohort of patients having CLP. This work also illustrates the utility of fetal MRI-
based analyses and establishes a novel mouse model for teratogen-induced CLP.
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Introduction
Clefts of the lip and/or palate (CL/P) represent the most common birth defect form present
in newborns, occurring in approximately 1 in 700 births (reviewed in Vieira, 2008). Of those
affected, 20% present with cleft lip (CL), 30% with cleft palate (CP), and 50% with cleft lip
and palate (CLP). These defects cause significant morbidity and require extensive medical
intervention (reviewed in Robin et al., 2006).
Research efforts to elucidate the etiology of CL/P have largely focused on possible genetic
causes. While several allelic variants have been identified that appear to exert predisposing
or protective effects, the majority of CL/P cases are considered non-Mendelian. Several
environmental factors have been identified that appear to increase the risk of clefting as
well, including maternal cigarette smoking, folic acid deficiency, and alcohol consumption
(Reviewed in Juriloff and Harris, 2008). However, the currently identified environmental
and genetic factors can independently account for only a minority of cases, fueling the
hypothesis that the majority of CLP cases have multifactorial etiologies involving the
interaction of genetic predisposition with environmental factors and/or teratogenic insults
(Murray, 2002; Graham and Shaw, 2007; Vieira, 2008).
In approximately 25% of all cases, clefts of the lip and palate present as part of a more
extensive syndrome. An increasing number of genes are being identified as playing a causal
role in these syndromic cases. Importantly however, it is clear that even in cases considered
nonsyndromic, CL/P preferentially co-occurs with a range of other clinical presentations
including congenital heart defects, mild structural brain anomalies, subtle cognitive deficits,
and altered pituitary function (Laron and Opitz, 1969; Roitman and Laron, 1978; Rudman et
al., 1978; Nopoulos et al., 2002; Swanenburg de Veye et al, 2003; Conrad et al., 2008;
Beriaghi et al., 2009).
Of particular significance for this investigation is the association of CL/P with a spectrum of
abnormalities termed holoprosencephaly (HPE). Characterized by median forebrain
deficiency, HPE typically co-occurs with median facial deficiencies, reduced interocular
distance, high arching or clefting of the palate, and median or lateral clefts of the lip
(Reviewed in Cohen, 2006 and Dubourg et al., 2007). HPE cases with lateral cleft lip
commonly share phenotypic overlap with other named syndromes including Kallmann
Syndrome and Oral-Facial-Digital Syndrome. While HPE occurs infrequently in live births
(1.3/10,000), its prevalence as well as its prenatal lethality or co-occurrence with lethal birth
defects, is illustrated by an incidence in conceptuses of approximately 1 in 250 (Matsunaga
and Shiota, 1977; Leoncini et al., 2008).
Human genetic analyses, as well as transgenic and teratogenic animal models, have provided
significant insight into the genesis of HPE. While interference with several signaling
networks, including Nodal, Wnt, BMP, and Hedgehog (Hh), can yield HPE phenotypes, the
latter pathway has been most extensively linked to the genesis of HPE (reviewed in
Schachter and Krauss, 2008). Sonic Hedgehog (Shh), encodes a secreted, cholesterol
modified ligand that initiates signal transduction, and is expressed in the prechordal plate,
ventral forebrain neuroepithelium, ventral facial ectoderm, and palatal oral epithelium
(Jeong et al., 2004, Cordero et al., 2004, Rice et al., 2005, Aoto et al., 2008). Shh
homozygous null mice exhibit severe HPE (Chiang et al., 1996), while heterozygous
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hypomorphic mutations in the Shh gene are associated with human HPE (Nanni et al., 1999,
Maity et al., 2005).
In addition to genetic abrogation, interference with Hh signaling by environmental agents
has been informative. The plant alkaloid, cyclopamine, is a specific Hh signaling antagonist
that was first shown in the 1960s to cause HPE-associated defects in sheep and has since
been employed in teratogenesis studies involving a variety of vertebrates (Keeler, 1978;
Omnell et al., 1990; Coventry et al., 1998). Cyclopamine inhibits the morphogenetic activity
of the Hh pathway by binding to, and preventing activation of the transmembrane protein
Smoothened (Smo) (Chen et al., 2002). In the absence of Hh ligand, its receptor, Patched
(Ptc1) inhibits Smo activity, presumptively through a small molecule mediator (Bijlsma et
al., 2006; Taipale et al., 2002). Upon Hh binding to Ptc1, inhibition of Smo is relieved,
triggering a complex downstream signaling cascade that culminates in target gene activation
via the Gli family of transcription factors (reviewed in Ingham and McMahon, 2001).
While Hh signaling perturbation is a well-established mechanism for induction of the
concurrent brain and face abnormalities that characterize HPE, recent studies suggest a
capacity for induction of facial dysmorphia independent of apparent gross brain defects. In
the chick, Shh expression in the neuroectoderm is required for induction of Hh signaling in
the adjacent face and expansion of the frontonasal prominence (Marcucio et al., 2005). Hh
signaling inhibition during neural plate patterning induces severe HPE, while inhibition
following establishment of Shh in the forebrain but prior to its induction in the face, results
in facial defects without apparent effects on the forebrain (Cordero et al., 2004). We have
previously demonstrated the induction of CLP in mice by cyclopamine exposure targeting
gestational day 8.25 (GD8.25) to GD9.5 (Lipinski et al., 2008a).
For the current investigation, we employed cyclopamine and a potent cyclopamine-analog to
examine a phenotypic spectrum resulting from transient in utero Hh signaling inhibition in
mice. For this work, along with traditional imaging and histological approaches, high
resolution magnetic resonance imaging (MRI) was utilized, facilitating the assessment of
craniofacial and CNS abnormalities.
Materials and Methods
In vitro cell culture assays
Dose-response assays in Shh LIGHTII NIH3T3 fibroblasts were performed as previously
described (Lipinski et al., 2007). Briefly, cells were plated in Multiwell Primaria 24-well
plates (Falcon, Franklin Lakes, NJ) at 1.5 × 105 cells/well in 400 μl media and allowed to
attach overnight. Media were then replaced with DMEM containing 1% fetal calf serum
(FCS) ± 1nM octylated human Shh peptide (Curis/Genentech) and cyclopamine (LC
Laboratories, Woburn, MA) or AZ75 (Astrazeneca, Waltham, MA) (from 5 mM stock
solutions dissolved in 95% ethanol), or vehicle alone. Following 48 hrs incubation, reporter
activity was determined by dual luciferase assay (Promega, Madison, WI).
Animals
All animal procedures were conducted in accordance with the University of Wisconsin
animal care guidelines. Timed pregnancies were established in-house. Two female C57BL/
6J (Jackson Laboratories, Bar Harbor, ME) mice at 12–16 weeks of age were housed with
one male C57BL/6J mouse overnight on a light cycle of 12 h on and 12 h off. The presence
of a vaginal plug the following morning was considered gestational day 0.5 (GD0.5).
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Cyclopamine was administered by subcutaneous infusion via micro-osmotic pump at a rate
of 160 mg/kg/d between GD8.25 and GD9.5 as previously described (Lipinski et al., 2008a).
AZ75, a synthetic cyclopamine-analog (AstraZeneca, Waltham, MA) was administered at
GD8.5 as a single oral gavage dose of 40 or 80 mg/kg in 500 μl 0.5% hydroxypropyl-
methylcellulose (Sigma-Aldrich, St. Louis, MO), 0.1% tween in water.
Specimen preparation
Fetal mice were fixed and stored in 10% formalin indefinitely. For images presented in
Figure 1, the fetuses were briefly soaked in ethidium bromide (1μg/ml PBS) and imaged
under ultraviolet light. For MRI analysis, the specimens were dehydrated in a 4% saline
solution for 24 h, and subsequently allowed to rehydrate in 5 mM Multihance® (Bracco
Diagnostics Inc., Princeton, NJ) (1:99 dilution with 0.9% saline) solution for at least 10 days
prior to imaging.
Magnetic Resonance Imaging
Multihance®-soaked fetuses were placed into a syringe containing Fluorinert (3M, St. Paul,
MN) and positioned centrally in a Varian n.m cm diameter quadrature coil. Images were
acquired at 4.7T using a Varian Inova imaging and spectroscopy system. A 3D gradient
echo sequence (Tr=20ms, Te=6.5 ms, Fl=65, FOV= 24×12×12mm, Ma=512×256×256,
NT=32) was used to acquire images with an isotropic resolution of approximately 47 μm.
Image construction
ImageJ (Abramoff, 2004) was used to construct 2D images and produce linear
measurements (Figures 4 and 5). 3D volume and surface renderings (Figure 4) were
obtained using Osirix4 (Rosset et al., 2004). Brain segmentation (Figure 5) was performed
using Amira® (version 4.1.1, Visage Imaging, Inc., San Diego, USA.).
Histology
Fetuses were fixed in Bouin’s solution (Sigma-Aldrich) for at least one week and then
transferred to 70% ethanol. Following paraffin embedding, 10 μm sections were produced
and stained with hematoxylin and eosin by standard protocols.
Scanning Electron Microscopy
Embryos at indicated stages were fixed in 2.5% glutaraldehyde in Sorenson’s buffer and
imaged by light microscopy. Specimens were then processed for imaging by scanning
electron microscopy as previously described (Dunty et al., 2002).
Statistical analysis
Linear and volumetric brain measurements were determined for the following sample sizes
for each group: Normal, n=4; CLP, n=6; HPE, n=6. Values shown represent mean ±
standard deviation. One way analyses of variance (ANOVA) were utilized to assess
differences in measurements among groups. Dunnett post hoc tests were used to follow-up
significant results, comparing CLP and. HPE groups against the normal group. An alpha-
value of 0.05 was maintained for all analyses.
Results
Cyclopamine was administered by subcutaneous infusion that extended from days 8.25 to
9.5 of pregnancy, representing a maternal dosage of 160 mg/kg/d. Cyclopamine exposure
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induced gross facial malformations in 5 of 14 litters with an approximate intra-litter
penetrance of 50%. One affected fetus exhibited unilateral CL while the majority presented
with unilateral (n=6) or bilateral CLP (n=12) as previously reported (Lipinski et al., 2008a;
Figure 1). Of the 18 fetuses featuring CLP, the medial nasal prominence-derived tissue mass
was markedly deficient in two (Figure 2C), and nearly absent in one (Figure 2D). The
varying facial morphologies present in these cyclopamine-exposed fetuses are comparable to
those occurring in human populations.
AZ75, a semi-synthetic cyclopamine-analog, demonstrated a four-fold greater potency for
Hh signaling inhibition than its parent compound cyclopamine in a ligand-responsive cell
line (supplemental Figure 1), with differences also notable in vivo. Whereas bolus
administration of cyclopamine has been associated with maternal toxicity (Lipinski et al.,
2008a), administration of AZ75 by oral gavage at doses of 40 mg/kg (n=7) and 80 mg/kg
(n=4) on day 8.5 of pregnancy produced no apparent toxicity in the dams. In exposed litters,
the 80 mg/kg dose caused all of the embryos to resorb. In the 40 mg/kg exposure group,
multiple surviving fetuses were found, with gross craniofacial malformations occurring in 6
of 7 litters.
Regarding craniofacial defects, AZ75 administered acutely by oral gavage on day 8.5 of
pregnancy resulted in abnormalities that are consistent with overt (alobar and semilobar)
HPE. Among six affected litters, approximately 40% of fetuses exhibited hypotelorism
(reduced interocular distance) and cebocephaly (small nose with a single nostril) (Figure
1D,E). In one litter, along with two fetuses exhibiting this phenotype, two littermates
presented with median CLP with an almost complete absence of medial nasal prominence-
derived tissue (Figure 1C).
To investigate the morphogenesis of cyclopamine-induced CLP, embryos were analyzed at
GD11.25, the gestational period closely following that in which the medial nasal, lateral
nasal, and maxillary prominences unite to form the upper lip (Reviewed by Jiang et al.,
2006; Figure 2). Cyclopamine-affected embryos presented with medial nasal prominences
that were too closely situated and for which the lower component – that from which the
philtrum and primary palate are derived – was reduced in size and failed to contact both the
maxillary and the lateral nasal prominences. Embryos were also analyzed at GD14.0, a time
when the maxillary prominence-derived secondary palatal shelves normally begin to elevate
to allow midline approximation and fusion. In embryos with cyclopamine-induced CL, the
secondary palatal shelves appeared to be of normal size and conformation. However, the
midface of affected embryos was slightly wider than normal (compare Fig. 2H and K), with
the anterior aspect of the palatal shelves being too widely spaced (compare Fig. 2I and L). In
severely holoprosencephalic embryos, where the midface is extremely narrow and the
primary palate is absent, the secondary palatal shelves were of relatively normal proportion
and were prematurely fused anteriorly.
For further detailed analysis, histological sections were produced from GD16.5 fetuses
selected by external appearance to represent the predominant phenotype associated with
exposure to vehicle (normal), cyclopamine (unilateral and bilateral CLP as depicted in
Figure 1F and G), and AZ75 (HPE of severity within the range seen in Figure 1D and E). In
the CLP group, both palatal shelves appeared properly elevated in one fetus, whereas in the
other three examined, one shelf was elevated while the contralateral was not (Figure 3).
Additionally, three of the four CLP specimens exhibited agenesis of the Rathke’s pouch-
derived anterior lobe of the pituitary gland. For the HPE group, histological sections
illustrated that the median facial deficiency reflected that in the forebrain. Olfactory bulb
agenesis, rostrally unified cerebral hemispheres (with striatal union), and complete agenesis
of the pituitary gland were observed. Additionally, palatal shelves were found to be fused
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but abnormally highly arched. No apparent changes in histological features of the midbrain
and hindbrain were observed in either group.
From selected fetuses, 48 μm isotropic MRI sections were reconstructed to provide 3-D
visualization of skeletal structure and brain surface morphology. Images representing
Normal, CLP, and HPE phenotypes are shown in Figure 4. While the CLP-associated
craniofacial skeletal structure was grossly normal, abnormal fusion of the frontal bones
(metopic craniosynostosis) was associated with the HPE phenotype, reflecting clinical
observations (Faro et al., 2005).
To quantitatively assess the CLP- and HPE-associated CNS phenotype, a series of linear
measurements was employed (adapted from Parnell et al. 2009). Mid-sagittal brain length,
biparietal diameter, transverse cerebellar distance, olfactory bulb length and width, and
interocular distance measurements were produced. Figure 5 illustrates linear measurement
parameters with corresponding quantitative graphical analysis. This analysis revealed a
significant reduction in olfactory bulb length (F(2, 13) = 592.1, p<0.001) and width (F(2,
13) = 473.4, p<0.001) associated with CLP. Holoprosencephalic fetuses exhibited reduced
biparietal diameter (F(2, 13) = 13.5, p<0.02) and brain length (F(2, 13) = 10.9, p<0.03),
olfactory bulb absence, and severely reduced inter-ocular distance (F(2, 13) = 17.1,
p<0.001). Cerebellum width in HPE fetuses was not significantly reduced (F(2, 13) = 3.7,
p<0.08).
Segmentation and 3-D reconstruction was used to examine brain morphology associated
with the described CLP and HPE phenotypes (Figure 5). As predicted from linear
measurements, a subtle but consistent hypoplasia of the olfactory bulbs was observed in
brains of mice with cyclopamine-induced CLP. No other gross morphological differences in
these brains were observed. As expected, striking forebrain abnormalities were observed in
the holoprosencephalic fetuses; most notably, median union of the cerebral hemispheres
accompanied by rostro-caudal foreshortening. While overall brain volume was unchanged in
the CLP group, it was significantly reduced in the HPE group (F(2, 13) = 13.6, p<0.001).
Discussion
Since the first description of cyclopamine-mediated teratogenicity, over 40 years ago, the
majority of teratology investigations regarding this compound have been directed toward
exploring the pathogenesis and mechanisms underlying HPE. This work has led to the
appreciation of cyclopamine as a Hh antagonist and helped to clarify the role of Hh
signaling in normal and abnormal development. Extending this line of investigation is the
work described herein, providing new insights into cyclopamine-induced CNS and facial
defects, and highlighting lateral cleft lip and palate as a manifestation of interference with
the Hh pathway. As indicated in a recent review (Gritli-Linde, 2008), our understanding of
the genesis of CLP has suffered from the relative infrequency of genetic and teratogen-
mediated CLP models. The mouse model established in this investigation holds significant
promise in this regard.
This study showed that among the fetuses presenting with lateral CLP, the facial
morphology varied. In some fetuses, the medial nasal prominence tissue was clearly
deficient in size and in others it was not. For the latter group, the clefts appear comparable to
those in clinical populations with “typical” cleft lip. The accompanying anterior pituitary
and olfactory bulb deficiencies in this group of animals, however, place the dysmorphology
within the HPE spectrum. This is important clinically. Several studies have described an
association between nonsyndromic CL/P and reduced body size attributable, at least in part,
to anterior pituitary dysfunction (Laron and Opitz, 1969; Roitman and Laron; 1978, Rudman
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et al., 1978; Bowers et al., 1987). The findings of the study by Rudman et al. (1978)
examining stature and endocrine function in a large clinical sample size suggested that
children with CL/P defects have short stature about four times more often, and growth
hormone-deficiency about 40 times more often, than children without CL/P. Additionally,
Richman et al., (1988) described a significant olfactory deficit in boys with CL/P. This,
along with increasing evidence of additional concurrent subtle brain malformations in CL/P
patients (Nopoulos et al., 2002, Nopoulos et al., 2007) strongly argues for increased clinical
attention to CNS abnormalities that may not be readily detectable and for additional CNS
analyses in CLP models.
Our analysis of cyclopamine-exposed embryos suggests that the described fetal phenotype
of anterior pituitary aplasia results from embryonic midline tissue deficiency. In these
animals, abnormal median approximation of the medial nasal prominences corresponds with
a deficient median aspect of the oral cavity, from which Rathke’s pouch evaginates. In
addition to median approximation, abnormal size and angle of the lower component of the
medial nasal prominences in affected embryos appears to be the basis for cyclopamine-
induced CL. That the secondary palatal shelves of cyclopamine-exposed embryos did not
appear deficient in size argues that the subsequent secondary palate cleft is not due to a
direct effect on growth of the maxillary prominence-derived shelves. Rather, we speculate
that a subtle increase in midface width, secondary to cyclopamine-induced CL, precludes
contact of the palatal shelves at the midline. Excessive midface width as a basis for CP
secondary to CL has been extensively proposed for both animal models and clinical
populations (Subtelny, 1955; Huddart et al.,1969; Smiley, 1971; Diewert, 1982)
As evidenced by the induction of an intermediate phenotype of median CLP (compare Fig.
1C and I), the two distinct drug administration regimens employed here produced a
phenotypic spectrum. We expect that differences in timing of exposure and/or potency of the
mechanistically identical drugs are responsible for their preferential induction of distinct
phenotypic forms. Elucidation of these factors may provide significant insight into the
dynamic role of Hh signaling in craniofacial and CNS development as well as distinct
phenotypes within the clinical spectrum of CLP and HPE, and will be the focus of future
studies.
As shown herein, for both CNS and craniofacial morphological analyses, MRI provides
numerous advantages over traditional histological approaches. This includes generation of
virtual 2-D sections in any plane, 3-D segment reconstruction, and acquisition of precise
linear and volumetric measurements of specific structures of interest. This study expands
upon a body of work illustrating the utility of MR-based fetal phenotypic assessment by
describing a novel specimen preparation and imaging methodology. While this protocol
does not replicate the contrast and resolution of that reported by Schneider et al., (2004) and
Petiet et al., (2008) respectively using 11.9 and 9.0 T magnets, it does produce 48 μm
isotropic resolution images allowing visualization and quantitation of gross fetal craniofacial
structures. This methodology also provides significant advantages as it is compatible with
post-fixation specimens, uses a more commonly available 4.7T magnet, and yields
remarkably accurate and detailed 3-D visualization of both soft and hard tissue structures.
Previous studies have shown that a number of different teratogens can induce HPE. This
includes acute exposure to retinoic acid, ethanol, and cholesterol biosynthesis inhibitors
(Sulik and Johnston 1983; Sulik et al., 1995; Incardona and Roelink, 2000). For at least the
latter two, interference with Hh signaling, appears to account for the induced defects
(Incardona and Roelink, 2000; Ahlgren et al., 2002; Li et al., 2007). Additionally, a
surprising number of structurally diverse synthetic and natural compounds have been
identified that act as direct Hh pathway inhibitors (Frank-Kamenetsky et al., 2002; Williams
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et al. 2003; Lipinski et al., 2007; Lauth et al., 2007). Efforts to better understand how these
agents may act in additive or synergistic fashions, as well as how normally silent genetic
mutations may alter sensitivity to such chemical insults should be pursued. Indeed, the
fidelity of craniofacial development between man and mouse (Diewart and Wang, 1992) and
the unmatched genetic manipulability of the latter, make the mouse an ideal model system in
which to investigate the interaction of chemical and genetic factors in the etiopathology of
complex birth defects such as CLP and HPE.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Hh signaling antagonist-induced CLP- and HPE- associated dyspmorphology
GD16.5 fetuses exposed to vehicle (A), cyclopamine (B, F–H), or the cyclopamine analog,
AZ75 (C–E). Cyclopamine exposure induced unilateral and bilateral CLP (B). AZ75
exposure predominantly induced severe holoprosencephalic phenotypes within the range
shown in D and E. An intermediate CLP phenotype presenting with severely deficient
medial nasal prominence derived tissue (C, I) was induced infrequently by both drug
administration regimens. The phenotypic range produced by cyclopamine exposure included
unilateral CLP (F), bilateral CLP with graded amounts of medial nasal prominence derived
tissue (G,H), and median CL with cleft palate (I). Correlate human phenotypes are shown
below. Images are presented courtesy of M. Muenke (J,L,M) and K. Sulik (K).
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Figure 2. Embryonic morphogenesis of cyclopamine-induced CLP
Bright field and scanning electron microscopy images of GD11.25 and 14.0 embryos
exposed to vehicle, cyclopamine, or AZ75. At GD11.25, the medial nasal (M), lateral nasal
(L), and maxillary (Mx) prominences have united in normal embryos (A–C) to form the
upper lip. In affected cyclopamine-exposed embryos (D–F), the medial nasal prominences
are too closely opposed at the juncture between the upper and lower aspects, with the lower
aspect (dashed outline) deficient in size and angle relative to normal. At GD14.5, in normal
embryos (G–I), the maxillary-derived secondary palatal shelves have fused with the primary
palate and begun to elevate (I). Cyclopamine-exposed embryos with unilateral CL (K) and
bilateral CL (L), exhibit excessive midface width (long dashed lines) and palatal shelves that
appear normal in size and conformation but are too widely spaced (short dashed lines) in the
anterior aspect. In AZ75-exposed cebocephalic embryos (M–O), the primary palate is absent
and secondary palatal shelves have prematurely fused anteriorly. Mandibular prominence
(Md).
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Figure 3. Histological analysis of CLP- and HPE-associated craniofacial and CNS phenotype
Hematoxylin and eosin-stained serial coronal sections of GD 16.5 fetuses exposed to vehicle
(A–F), cyclopamine (G–L), or AZ75 (M–R). Notable CLP-associated features include small
secondary palate shelves (I) and anterior pituitary gland agenesis (J). Notable HPE-
associated features include absent nasal septum cartilage (M), olfactory bulb agenesis (N),
rostral union of the cerebral hemispheres with fused striatum (O), and complete pituitary
gland agenesis (P). Sections D and J were chosen because they feature the most prominent
pituitary gland mass. No apparent differences in midbrain and hindbrain features were
noted.
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Figure 4. MRI-based fetal phenotypic analysis
3-D volume (A,E,I) and surface rendering (D,H,L) and 2D sections (B,C,F,G,J,K) reveal
external and internal CLP- and HPE-associated dysmorphology. Cleft lip is indicated by
black arrows while white arrowheads note secondary palate structure. White arrows note
cranial frontal bones which are abnormally fused (metopic craniosyntosis) in the HPE fetus
(L).
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Figure 5. HPE and CLP associated CNS phenotype
Linear measurements (arbitrary units) were produced from serial transverse sections.
Olfactory bulb (OFB) length and width were reduced in the CLP group. In the HPE group,
biparietal diameter, brain length, and interocular distance were reduced and olfactory bulbs
were absent. 3-D whole brain reconstructions were produced from MRI data (boxed). ofb –
olfactory bulb; cer – cerebral hemisphere; mb – midbrain. Plot shows corresponding
quantitation of total brain volume. A subtle but consistent hypoplasia of the olfactory bulbs
was found in the CLP group. In the HPE group, median union and rostro-caudal
foreshortening of the cerebral hemispheres was found along with a gross reduction in brain
volume.
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